Literature DB >> 2039762

Event-related potentials in schizophrenia: their biological and clinical correlates and a new model of schizophrenic pathophysiology.

R W McCarley1, S F Faux, M E Shenton, P G Nestor, J Adams.   

Abstract

Evidence is growing that schizophrenic patients show significant structural damage in the temporal lobe limbic system. We review event-related potentials abnormalities (ERPs) in schizophrenia that may be related to dysfunction in this brain region or its inputs; ERPs discussed include the N100/P200, P300 and N400 components. Additional CT and clinical data have led our laboratory to a unifying working hypothesis of the presence of temporal lobe damage in schizophrenics that is evinced electrophysiologically as ERP alterations, structurally as tissue loss/derangement, and clinically as positive symptoms. The final section of this paper presents a new model of at least one form of schizophrenic pathology that, while speculative, incorporates experimentally based data from both our ERP work and from basic cellular physiology and pharmacology. The model proposes that positive symptoms of schizophrenia are related to limbic system pathology and in particular to a dysregulation of the NMDA form of excitatory amino acid transmission, potentiated by stress, and leading to cell damage and death due to 'excitotoxicity'.

Entities:  

Mesh:

Year:  1991        PMID: 2039762     DOI: 10.1016/0920-9964(91)90034-o

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  47 in total

Review 1.  Biomarkers for the effects of antipsychotic drugs in healthy volunteers.

Authors:  S J de Visser; J van der Post; M S Pieters; A F Cohen; J M van Gerven
Journal:  Br J Clin Pharmacol       Date:  2001-02       Impact factor: 4.335

Review 2.  Cognitive dysfunction in schizophrenia: unifying basic research and clinical aspects.

Authors:  R W McCarley; M A Niznikiewicz; D F Salisbury; P G Nestor; B F O'Donnell; Y Hirayasu; H Grunze; R W Greene; M E Shenton
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

Review 3.  Scent of a disorder: olfactory functioning in schizophrenia.

Authors:  Paul J Moberg; Bruce I Turetsky
Journal:  Curr Psychiatry Rep       Date:  2003-08       Impact factor: 5.285

4.  Reduced glutamate decarboxylase 65 protein within primary auditory cortex inhibitory boutons in schizophrenia.

Authors:  Caitlin E Moyer; Kristen M Delevich; Kenneth N Fish; Josephine K Asafu-Adjei; Allan R Sampson; Karl-Anton Dorph-Petersen; David A Lewis; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2012-05-23       Impact factor: 13.382

5.  ERP generator patterns in schizophrenia during tonal and phonetic oddball tasks: effects of response hand and silent count.

Authors:  Jürgen Kayser; Craig E Tenke; Roberto Gil; Gerard E Bruder
Journal:  Clin EEG Neurosci       Date:  2010-10       Impact factor: 1.843

Review 6.  rTMS strategies for the study and treatment of schizophrenia: a review.

Authors:  Arielle D Stanford; Zafar Sharif; Cheryl Corcoran; Nina Urban; Dolores Malaspina; Sarah H Lisanby
Journal:  Int J Neuropsychopharmacol       Date:  2008-02-01       Impact factor: 5.176

7.  Impairment in Mismatch Negativity but not Repetition Suppression in Schizophrenia.

Authors:  Brian A Coffman; Sarah M Haigh; Tim K Murphy; Dean F Salisbury
Journal:  Brain Topogr       Date:  2017-05-17       Impact factor: 3.020

8.  Method for multimodal analysis of independent source differences in schizophrenia: combining gray matter structural and auditory oddball functional data.

Authors:  V D Calhoun; T Adali; N R Giuliani; J J Pekar; K A Kiehl; G D Pearlson
Journal:  Hum Brain Mapp       Date:  2006-01       Impact factor: 5.038

9.  Profile of auditory information-processing deficits in schizophrenia.

Authors:  Bruce I Turetsky; Warren B Bilker; Steven J Siegel; Christian G Kohler; Raquel E Gur
Journal:  Psychiatry Res       Date:  2008-11-06       Impact factor: 3.222

Review 10.  Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.

Authors:  Evan Noch; Kamel Khalili
Journal:  Cancer Biol Ther       Date:  2009-10       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.